Able 0 4 0 4 O
to 5 7 5 7 O
take 8 12 8 12 O
aspirin 13 20 13 20 B-treatment
( 21 22 21 22 O
81 22 24 22 24 B-lower_bound
or 25 27 25 27 O
325 28 31 28 31 B-upper_bound
mg 32 34 32 34 I-upper_bound
) 34 35 34 35 O
daily 36 41 36 41 O
for 42 45 42 45 O
prophylactic 46 58 46 58 B-treatment
anticoagulation 59 74 59 74 I-treatment

Able 0 4 75 79 O
to 5 7 80 82 O
take 8 12 83 87 O
aspirin 13 20 88 95 B-treatment
( 21 22 96 97 O
81 22 24 97 99 B-lower_bound
or 25 27 100 102 O
325 28 31 103 106 B-upper_bound
mg 32 34 107 109 I-upper_bound
) 34 35 109 110 O
daily 36 41 111 116 O
for 42 45 117 120 O
prophylactic 46 58 121 133 B-treatment
anticoagulation 59 74 134 149 I-treatment
( 75 76 150 151 O
patients 76 84 151 159 O
intolerant 85 95 160 170 O
to 96 98 171 173 O
acetylsalicylic 99 114 174 189 B-allergy_name
acid 115 119 190 194 I-allergy_name
, 119 120 194 195 O
ASA 121 124 196 199 B-allergy_name
, 124 125 199 200 O
may 126 129 201 204 O
use 130 133 205 208 O
warfarin 134 142 209 217 B-treatment
or 143 145 218 220 O
low 146 149 221 224 B-treatment
molecular 150 159 225 234 I-treatment
weight 160 166 235 241 I-treatment
heparin 167 174 242 249 I-treatment
or 175 177 250 252 O
other 178 183 253 258 O
anticoagulants 184 198 259 273 B-treatment
as 199 201 274 276 O
deemed 202 208 277 283 O
appropriate 209 220 284 295 O
by 221 223 296 298 O
physician 224 233 299 308 O
) 233 234 308 309 O

Absolute 0 8 310 318 B-clinical_variable
neutrophil 9 19 319 329 I-clinical_variable
count 20 25 330 335 I-clinical_variable
> 26 27 336 337 O
= 27 28 337 338 O
750 29 32 339 342 B-lower_bound
/ 32 33 342 343 I-lower_bound
mm^3 33 37 343 347 I-lower_bound

Any 0 3 348 351 O
prior 4 9 352 357 O
autoimmune 10 20 358 368 B-chronic_disease
disorders 21 30 369 378 I-chronic_disease
requiring 31 40 379 388 O
cytotoxic 41 50 389 398 B-treatment
or 51 53 399 401 O
immunosuppressive 54 71 402 419 B-treatment
therapy 72 79 420 427 I-treatment
or 80 82 428 430 O
autoimmune 83 93 431 441 O
disorders 94 103 442 451 O
with 104 108 452 456 O
visceral 109 117 457 465 O
involvement 118 129 466 477 O

Any 0 3 478 481 O
serious 4 11 482 489 O
medical 12 19 490 497 O
condition 20 29 498 507 O
, 29 30 507 508 O
laboratory 31 41 509 519 O
abnormality 42 53 520 531 O
, 53 54 531 532 O
or 55 57 533 535 O
psychiatric 58 69 536 547 B-chronic_disease
illness 70 77 548 555 I-chronic_disease
that 78 82 556 560 O
would 83 88 561 566 O
prevent 89 96 567 574 O
the 97 100 575 578 O
subject 101 108 579 586 O
from 109 113 587 591 O
signing 114 121 592 599 O
the 122 125 600 603 O
informed 126 134 604 612 O
consent 135 142 613 620 O
form 143 147 621 625 O

Aspartate 0 9 626 635 B-clinical_variable
aminotransferase 10 26 636 652 I-clinical_variable
( 27 28 653 654 I-clinical_variable
AST 28 31 654 657 I-clinical_variable
) 31 32 657 658 I-clinical_variable

Chemotherapy 0 12 659 671 B-treatment
, 12 13 671 672 O
immunotherapy 14 27 673 686 B-treatment
, 27 28 686 687 O
radiotherapy 29 41 688 700 B-treatment
, 41 42 700 701 O
radiosurgery 43 55 702 714 B-treatment
, 55 56 714 715 O
interferon 57 67 716 726 B-treatment
( 68 69 727 728 O
e.g. 69 73 728 732 O
Intron 74 80 733 739 B-treatment
- 80 81 739 740 I-treatment
A 81 82 740 741 I-treatment
® 82 83 741 742 I-treatment
) 83 84 742 743 O
, 84 85 743 744 O
allergy 86 93 745 752 B-treatment
desensitization 94 109 753 768 I-treatment
injections 110 120 769 779 I-treatment
, 120 121 779 780 O
growth 122 128 781 787 O
factors 129 136 788 795 O
( 137 138 796 797 O
e.g. 138 142 797 801 O
Procrit 143 150 802 809 B-treatment
® 150 151 809 810 I-treatment
, 151 152 810 811 O
Aranesp 153 160 812 819 B-treatment
® 160 161 819 820 I-treatment
, 161 162 820 821 O
Neulasta 163 171 822 830 B-treatment
® 171 172 830 831 I-treatment
) 172 173 831 832 O
, 173 174 832 833 O
interleukins 175 187 834 846 B-treatment
( 188 189 847 848 I-treatment
e.g. 189 193 848 852 I-treatment
Proleukin 194 203 853 862 I-treatment
® 203 204 862 863 I-treatment
) 204 205 863 864 I-treatment
or 206 208 865 867 O
any 209 212 868 871 O
investigational 213 228 872 887 O
therapeutic 229 240 888 899 O
medication 241 251 900 910 O
within 252 258 911 917 O
4 259 260 918 919 B-upper_bound
weeks 261 266 920 925 I-upper_bound
of 267 269 926 928 O
study 270 275 929 934 O
entry 276 281 935 940 O

Creatinine 0 10 941 951 B-clinical_variable
clearance 11 20 952 961 I-clinical_variable
> 21 22 962 963 O
= 22 23 963 964 O
30 24 26 965 967 B-lower_bound
mL 27 29 968 970 I-lower_bound
/ 29 30 970 971 I-lower_bound
minutes 30 37 971 978 I-lower_bound

Disease 0 7 979 986 O
free 8 12 987 991 O
of 13 15 992 994 O
prior 16 21 995 1000 O
malignancies 22 34 1001 1013 B-cancer
for 35 38 1014 1017 O
> 39 40 1018 1019 O
2 41 42 1020 1021 B-lower_bound
years 43 48 1022 1027 I-lower_bound
with 49 53 1028 1032 O
exception 54 63 1033 1042 O
of 64 66 1043 1045 O
currently 67 76 1046 1055 O
treated 77 84 1056 1063 O
basal 85 90 1064 1069 B-cancer
cell 91 95 1070 1074 I-cancer
carcinoma 96 105 1075 1084 I-cancer
, 105 106 1084 1085 O
squamous 107 115 1086 1094 B-cancer
cell 116 120 1095 1099 I-cancer
carcinoma 121 130 1100 1109 I-cancer
of 131 133 1110 1112 I-cancer
the 134 137 1113 1116 I-cancer
skin 138 142 1117 1121 I-cancer
, 142 143 1121 1122 O
or 144 146 1123 1125 O
carcinoma 147 156 1126 1135 B-cancer
in 157 159 1136 1138 I-cancer
situ 160 164 1139 1143 I-cancer
of 165 167 1144 1146 I-cancer
the 168 171 1147 1150 I-cancer
cervix 172 178 1151 1157 I-cancer
or 179 181 1158 1160 I-cancer
breast 182 188 1161 1167 I-cancer

Eastern 0 7 1168 1175 B-clinical_variable
Cooperative 8 19 1176 1187 I-clinical_variable
Oncology 20 28 1188 1196 I-clinical_variable
Group 29 34 1197 1202 I-clinical_variable
( 35 36 1203 1204 I-clinical_variable
ECOG 36 40 1204 1208 I-clinical_variable
) 40 41 1208 1209 I-clinical_variable
performance 42 53 1210 1221 I-clinical_variable
status 54 60 1222 1228 I-clinical_variable
of 61 63 1229 1231 O
= 64 65 1232 1233 O
< 65 66 1233 1234 O
2 67 68 1235 1236 B-upper_bound
at 69 71 1237 1239 O
study 72 77 1240 1245 O
entry 78 83 1246 1251 O

Females 0 7 1252 1259 B-gender
of 8 10 1260 1262 O
reproductive 11 23 1263 1275 O
potential 24 33 1276 1285 O
must 34 38 1286 1290 O
adhere 39 45 1291 1297 O
to 46 48 1298 1300 O
the 49 52 1301 1304 O
scheduled 53 62 1305 1314 O
pregnancy 63 72 1315 1324 B-pregnancy
testing 73 80 1325 1332 O
as 81 83 1333 1335 O
required 84 92 1336 1344 O
in 93 95 1345 1347 O
the 96 99 1348 1351 O
Revlimid 100 108 1352 1360 O
REMS 109 113 1361 1365 O
® 113 114 1365 1366 O
program 115 122 1367 1374 O

Known 0 5 1375 1380 O
hypersensitivity 6 22 1381 1397 O
to 23 25 1398 1400 O
thalidomide 26 37 1401 1412 B-allergy_name
, 37 38 1412 1413 O
lenalidomide 39 51 1414 1426 B-allergy_name
, 51 52 1426 1427 O
Keyhole 53 60 1428 1435 B-allergy_name
Limpet 61 67 1436 1442 I-allergy_name
Hemocyanin 68 78 1443 1453 I-allergy_name
( 79 80 1454 1455 I-allergy_name
KLH 80 83 1455 1458 I-allergy_name
) 83 84 1458 1459 I-allergy_name
, 84 85 1459 1460 O
or 86 88 1461 1463 O
granulocyte 89 100 1464 1475 B-allergy_name
colony 101 107 1476 1482 I-allergy_name
- 107 108 1482 1483 I-allergy_name
macrophage 108 118 1483 1493 I-allergy_name
stimulating 119 130 1494 1505 I-allergy_name
factor 131 137 1506 1512 I-allergy_name
( 138 139 1513 1514 I-allergy_name
GM 139 141 1514 1516 I-allergy_name
- 141 142 1516 1517 I-allergy_name
CSF 142 145 1517 1520 I-allergy_name
) 145 146 1520 1521 I-allergy_name

Known 0 5 1522 1527 O
seropositive 6 18 1528 1540 O
for 19 22 1541 1544 O
or 23 25 1545 1547 O
active 26 32 1548 1554 O
viral 33 38 1555 1560 B-chronic_disease
infection 39 48 1561 1570 I-chronic_disease
with 49 53 1571 1575 O
human 54 59 1576 1581 B-chronic_disease
immunodeficiency 60 76 1582 1598 I-chronic_disease
virus 77 82 1599 1604 I-chronic_disease
( 83 84 1605 1606 I-chronic_disease
HIV 84 87 1606 1609 I-chronic_disease
) 87 88 1609 1610 I-chronic_disease
, 88 89 1610 1611 O
hepatitis 90 99 1612 1621 B-chronic_disease
B 100 101 1622 1623 I-chronic_disease
virus 102 107 1624 1629 I-chronic_disease
( 108 109 1630 1631 I-chronic_disease
HBV 109 112 1631 1634 I-chronic_disease
) 112 113 1634 1635 I-chronic_disease
or 114 116 1636 1638 O
hepatitis 117 126 1639 1648 B-chronic_disease
C 127 128 1649 1650 I-chronic_disease
virus 129 134 1651 1656 I-chronic_disease
( 135 136 1657 1658 I-chronic_disease
HCV 136 139 1658 1661 I-chronic_disease
) 139 140 1661 1662 I-chronic_disease

Life 0 4 1663 1667 B-clinical_variable
expectancy 5 15 1668 1678 I-clinical_variable
less 16 20 1679 1683 O
than 21 25 1684 1688 O
4 26 27 1689 1690 B-upper_bound
months 28 34 1691 1697 I-upper_bound

Must 0 4 1698 1702 O
be 5 7 1703 1705 O
free 8 12 1706 1710 O
of 13 15 1711 1713 O
systemic 16 24 1714 1722 B-chronic_disease
infection 25 34 1723 1732 I-chronic_disease

Patients 0 8 1733 1741 O
had 9 12 1742 1745 O
prior 13 18 1746 1751 B-treatment
autologous 19 29 1752 1762 I-treatment
or 30 32 1763 1765 O
allogeneic 33 43 1766 1776 B-treatment
stem 44 48 1777 1781 I-treatment
cell 49 53 1782 1786 I-treatment
transplant 54 64 1787 1797 I-treatment

Patients 0 8 1798 1806 O
with 9 13 1807 1811 O
a 14 15 1812 1813 O
known 16 21 1814 1819 O
diagnosis 22 31 1820 1829 O
of 32 34 1830 1832 O
plasma 35 41 1833 1839 B-cancer
cell 42 46 1840 1844 I-cancer
leukemia 47 55 1845 1853 I-cancer

Patients 0 8 1854 1862 O
with 9 13 1863 1867 O
newly 14 19 1868 1873 O
diagnosed 20 29 1874 1883 O
multiple 30 38 1884 1892 B-cancer
myeloma 39 46 1893 1900 I-cancer
who 47 50 1901 1904 O
have 51 55 1905 1909 O
at 56 58 1910 1912 O
least 59 64 1913 1918 O
a 65 66 1919 1920 O
partial 67 74 1921 1928 O
response 75 83 1929 1937 O
after 84 89 1938 1943 O
induction 90 99 1944 1953 B-treatment
therapy 100 107 1954 1961 I-treatment
based 108 113 1962 1967 O
on 114 116 1968 1970 O
the 117 120 1971 1974 O
International 121 134 1975 1988 O
Working 135 142 1989 1996 O
Group 143 148 1997 2002 O
( 149 150 2003 2004 O
IWG 150 153 2004 2007 O
) 153 154 2007 2008 O
Uniform 155 162 2009 2016 O
Response 163 171 2017 2025 O
Criteria 172 180 2026 2034 O

Platelet 0 8 2035 2043 B-clinical_variable
count 9 14 2044 2049 I-clinical_variable
> 15 16 2050 2051 O
= 16 17 2051 2052 O
30,000 18 24 2053 2059 B-lower_bound
/ 24 25 2059 2060 I-lower_bound
mm^3 25 29 2060 2064 I-lower_bound

Pregnant 0 8 2065 2073 B-pregnancy

Systemic 0 8 2074 2082 B-clinical_variable
corticosteroid 9 23 2083 2097 I-clinical_variable
therapy 24 31 2098 2105 I-clinical_variable
> 32 33 2106 2107 O
2 34 35 2108 2109 B-lower_bound
mg 36 38 2110 2112 I-lower_bound
of 39 41 2113 2115 O
dexamethasone 42 55 2116 2129 B-treatment
or 56 58 2130 2132 O
equivalent 59 69 2133 2143 O
per 70 73 2144 2147 O
day 74 77 2148 2151 O
at 78 80 2152 2154 O
study 81 86 2155 2160 O
entry 87 92 2161 2166 O

The 0 3 2167 2170 O
development 4 15 2171 2182 O
of 16 18 2183 2185 O
erythema 19 27 2186 2194 B-chronic_disease
nodosum 28 35 2195 2202 I-chronic_disease
if 36 38 2203 2205 O
characterized 39 52 2206 2219 O
by 53 55 2220 2222 O
a 56 57 2223 2224 O
desquamating 58 70 2225 2237 O
rash 71 75 2238 2242 O
while 76 81 2243 2248 O
taking 82 88 2249 2255 O
thalidomide 89 100 2256 2267 B-treatment
or 101 103 2268 2270 O
similar 104 111 2271 2278 O
drugs 112 117 2279 2284 O

Total 0 5 2285 2290 O
bilirubin 6 15 2291 2300 B-clinical_variable
= 16 17 2301 2302 O
< 17 18 2302 2303 O
2 19 20 2304 2305 B-upper_bound
mg 21 23 2306 2308 I-upper_bound
/ 23 24 2308 2309 I-upper_bound
dL 24 26 2309 2311 I-upper_bound

breast 0 6 2312 2318 O
feeding 7 14 2319 2326 O
females 15 22 2327 2334 B-gender

lactating 0 9 2335 2344 O
females 10 17 2345 2352 B-gender
must 18 22 2353 2357 O
agree 23 28 2358 2363 O
not 29 32 2364 2367 O
to 33 35 2368 2370 O
breast 36 42 2371 2377 O
feed 43 47 2378 2382 O
while 48 53 2383 2388 O
taking 54 60 2389 2395 O
lenalidomide 61 73 2396 2408 B-treatment

patients 0 8 2409 2417 O
who 9 12 2418 2421 O
are 13 16 2422 2425 O
seropositive 17 29 2426 2438 O
because 30 37 2439 2446 O
of 38 40 2447 2449 O
hepatitis 41 50 2450 2459 B-treatment
B 51 52 2460 2461 I-treatment
virus 53 58 2462 2467 I-treatment
vaccine 59 66 2468 2475 I-treatment

serum 0 5 2476 2481 B-clinical_variable
glutamic 6 14 2482 2490 I-clinical_variable
oxaloacetic 15 26 2491 2502 I-clinical_variable
transaminase 27 39 2503 2515 I-clinical_variable
[ 40 41 2516 2517 I-clinical_variable
SGOT 41 45 2517 2521 I-clinical_variable
] 45 46 2521 2522 I-clinical_variable
) 46 47 2522 2523 O
and 48 51 2524 2527 O
alanine 52 59 2528 2535 B-clinical_variable
aminotransferase 60 76 2536 2552 I-clinical_variable
( 77 78 2553 2554 I-clinical_variable
ALT 78 81 2554 2557 I-clinical_variable
) 81 82 2557 2558 I-clinical_variable
( 83 84 2559 2560 O
serum 84 89 2560 2565 B-clinical_variable
glutamate 90 99 2566 2575 I-clinical_variable
pyruvate 100 108 2576 2584 I-clinical_variable
transaminase 109 121 2585 2597 I-clinical_variable
[ 122 123 2598 2599 I-clinical_variable
SGPT 123 127 2599 2603 I-clinical_variable
] 127 128 2603 2604 I-clinical_variable
) 128 129 2604 2605 O
= 130 131 2606 2607 O
< 131 132 2607 2608 O
3 133 134 2609 2610 B-upper_bound
x 135 136 2611 2612 I-upper_bound
upper 137 142 2613 2618 I-upper_bound
limit 143 148 2619 2624 I-upper_bound
of 149 151 2625 2627 I-upper_bound
normal 152 158 2628 2634 I-upper_bound
( 159 160 2635 2636 I-upper_bound
ULN 160 163 2636 2639 I-upper_bound
) 163 164 2639 2640 I-upper_bound

subjects 0 8 2641 2649 O
on 9 11 2650 2652 O
antibiotic 12 22 2653 2663 B-treatment
therapy 23 30 2664 2671 I-treatment
must 31 35 2672 2676 O
be 36 38 2677 2679 O
off 39 42 2680 2683 O
antibiotics 43 54 2684 2695 B-treatment
for 55 58 2696 2699 O
at 59 61 2700 2702 O
least 62 67 2703 2708 O
7 68 69 2709 2710 B-lower_bound
days 70 74 2711 2715 I-lower_bound
before 75 81 2716 2722 O
beginning 82 91 2723 2732 O
treatment 92 101 2733 2742 B-treatment

subjects 0 8 2743 2751 O
with 9 13 2752 2756 O
active 14 20 2757 2763 B-chronic_disease
infections 21 31 2764 2774 I-chronic_disease
( 32 33 2775 2776 O
whether 33 40 2776 2783 O
or 41 43 2784 2786 O
not 44 47 2787 2790 O
they 48 52 2791 2795 O
require 53 60 2796 2803 O
antibiotic 61 71 2804 2814 B-treatment
therapy 72 79 2815 2822 I-treatment
) 79 80 2822 2823 O
may 81 84 2824 2827 O
be 85 87 2828 2830 O
eligible 88 96 2831 2839 O
after 97 102 2840 2845 O
complete 103 111 2846 2854 O
resolution 112 122 2855 2865 O
of 123 125 2866 2868 O
the 126 129 2869 2872 O
infection 130 139 2873 2882 O

